Cancer News and Research

Latest Cancer News and Research

Inovio Biomedical records $2.9 million revenues in the six months ended June 30, 2009

Inovio Biomedical Corporation (NYSE AMEX: INO) (“Inovio”) today reported financial results for the three and six months ended June 30, 2009. Total revenue of $2.5 million and $2.9 million for the three and six months ended June 30, 2009, compared to $663,000 and $1.3 million for the three and six months ended June 30, 2008, respectively.

20 Aug 2009

Thyroid cancer patients treated successfully using a new robot-assisted endoscopic technique

Using a novel robot-assisted endoscopic technique, a team of surgeons at Yonsei University College of Medicine in Seoul, Korea, has successfully treated 200 consecutive patients with thyroid cancer. The minimally invasive operation, which has several technical and cosmetic benefits that the traditional open operation does not offer, is described in the August issue of the Journal of the American College of Surgeons.

20 Aug 2009

Siemens' state-of-the-art high-definition PET/CT scanner installed at Long Beach PET Imaging Center

Long Beach PET Imaging Center, a leading diagnostic imaging center in the Long Beach, Calif.-area, announced today it has completed the installation of a new state-of-the-art HD (high-definition) PET/CT scanner, the first of its kind in the area.

20 Aug 2009

Study finds long-term exposure to progesterone may lead to growth of tumors

Scientists at Michigan State University have found exposure to the hormone progesterone activates genes that trigger inflammation in the mammary gland.

20 Aug 2009

Study unveils detrimental effects of high-dose ursodeoxycholic acid on patients with PSC

Primary sclerosing cholangitis (PSC) is an uncommon chronic liver disease characterized by progressive inflammation and destruction of the bile ducts. The disease progresses slowly, usually leading to biliary cirrhosis, portal hypertension and liver failure over a 10-15 year period. PSC is a common cause of adult cholestatic liver diseases and a primary source behind many of the liver transplantations in U.S. adults. At least 70% of PSC cases are associated with chronic inflammatory bowel disease (IBD), usually ulcerative colitis. Currently, there is no cure for PSC and prospective treatments remain ineffective.

20 Aug 2009

Low income women less likely to be screened for cancer in Ontario

Less than half of Ontario women with abnormal Pap tests receive recommended and potentially life-saving follow-up care, according to a new women's health study by researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). What's more, low-income women are less likely to be screened for cancer compared to their high-income counterparts.

20 Aug 2009

Researcher of LA BioMed elected to distinguished fellow status of SVS

Carlos E. Donayre, MD, a researcher at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), has been elected to distinguished fellow status of the Society for Vascular Surgery- (SVS).

20 Aug 2009

Vanderbilt enters Chemical Biology Consortium as a Chemical Diversity Center to develop cancer treatment drugs

Vanderbilt University has been selected as one of 10 centers in the nation to participate in the Chemical Biology Consortium (CBC), a major new initiative to facilitate the discovery and development of new agents to treat cancer.

20 Aug 2009

Official launch of the FocusUP website announced

HST Global, Inc. today announced the official launch of the FocusUP® Website located at www.focusup.com FocusUP is the cognitive function product endorsed and recommended by Dr. Kyl Smith under a Joint Venture with Dalham, LLC (an affiliate company of The Health Network, Inc.).

20 Aug 2009

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.

20 Aug 2009

InterMed Discovery acquires microbial Omega-3 fatty acid production strains from the University of Saarland

InterMed Discovery (IMD), a world class natural product lead-discovery company, today announced the acquisition of unique microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland.

20 Aug 2009

Scientists develop new technique to target brain cancer cells

Scientists from the U.S. Department of Energy's (DOE) Argonne National Laboratory and the University of Chicago's Brain Tumor Center have developed a way to target brain cancer cells using inorganic titanium dioxide nanoparticles bonded to soft biological material.

20 Aug 2009

GHX OnDemand AP software-as-a-service solution helps hospitals reduce invoicing processing costs

A growing number of healthcare providers are using the OnDemand AP(SM) solution by GHX to automate and streamline their accounts payable processes, reducing invoice processing costs and cycle time, and improving internal controls and cash flow management. With OnDemand AP, hospitals can receive 100 percent of their invoices electronically, even from suppliers who do not currently support electronic invoicing. By eliminating the need for manual data entry and accelerating invoice approval, hospitals can reduce invoicing processing costs by more than 80 percent.

20 Aug 2009

National Science Foundation funds CMU for developing revolutionary computational tools

A multidisciplinary team led by Carnegie Mellon University computer scientist Edmund M. Clarke has received a five-year, $10 million grant from the National Science Foundation's Expeditions in Computing program to create revolutionary computational tools that will advance science on a broad array of fronts, from discovering new cancer treatments to designing safer aircraft.

20 Aug 2009

DNA-encased carbon nanotubes used for treating human prostate cancer tumors in mice

Researchers at Wake Forest University School of Medicine have destroyed prostate cancer tumors in mice by injecting them with specially-coated, miniscule carbon tubes and then superheating the tubes with a brief zap of a laser.

20 Aug 2009

AMDL reports revenues of $3.2 million for second quarter of 2009

AMDL Inc., a US-based pharmaceutical company with major operations in China, today reported unaudited results and the filing of its Form 10-Q with the Securities and Exchange Commission ("SEC") for fiscal second quarter 2009.

19 Aug 2009

Brits risk late cancer diagnosis because of poor symptom awareness

One in seven people cannot name a single symptom of cancer, according to a Cancer Research UK survey published Monday.

19 Aug 2009

Steroid hormones found to affect gene activity

Intermittent signaling by steroid hormones can affect the way genes are expressed in rodents, according to research by scientists at the University of Bristol and the National Cancer Institute (NCI), USA. This work has major implications for understanding how steroids work and opens novel avenues for new therapies.

19 Aug 2009

Nano-bio material kills cancer cells, leaves healthy cells in unharmed

19 Aug 2009

News outlets continue to explain how end-of-life care counseling works

NPR talks with Dr. David Casarett, associate professor of medicine at the University of Pennsylvania who started the palliative care service at the VA hospital in Philadelphia, about "the rhetoric around the end-of-life issues addressed in some of the proposed health care legislation" (Block, 8/18).

19 Aug 2009

Cancer News and Research

Latest Cancer News and Research

Inovio Biomedical records $2.9 million revenues in the six months ended June 30, 2009

Thyroid cancer patients treated successfully using a new robot-assisted endoscopic technique

Siemens' state-of-the-art high-definition PET/CT scanner installed at Long Beach PET Imaging Center

Study finds long-term exposure to progesterone may lead to growth of tumors

Study unveils detrimental effects of high-dose ursodeoxycholic acid on patients with PSC

Low income women less likely to be screened for cancer in Ontario

Researcher of LA BioMed elected to distinguished fellow status of SVS

Vanderbilt enters Chemical Biology Consortium as a Chemical Diversity Center to develop cancer treatment drugs

Official launch of the FocusUP website announced

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

InterMed Discovery acquires microbial Omega-3 fatty acid production strains from the University of Saarland

Scientists develop new technique to target brain cancer cells

GHX OnDemand AP software-as-a-service solution helps hospitals reduce invoicing processing costs

National Science Foundation funds CMU for developing revolutionary computational tools

DNA-encased carbon nanotubes used for treating human prostate cancer tumors in mice

AMDL reports revenues of $3.2 million for second quarter of 2009

Brits risk late cancer diagnosis because of poor symptom awareness

Steroid hormones found to affect gene activity

Nano-bio material kills cancer cells, leaves healthy cells in unharmed

News outlets continue to explain how end-of-life care counseling works

Understanding the DNA Damage Response in Innate Immunity eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in